• 1. Department of Respiratory and Critial Care Medicine, Beijing Hospital, Beijing, 100730, China;
  • 2. ;
XuXiaomao, Email: xuxiaomao@163.com
Export PDF Favorites Scan Get Citation

Objective  To describe the clinical profiles of cardiac arrest due to fatal pulmonary embolism (FPE), and review the literature on FPE diagnosis and treatment. Methods  The clinical profiles of two cases with cardiac arrest for FPE were presented. A systematic search of Medline (1950 - 2014) and EMbase (1980-2014) was conducted to identify studies that investigated the use of thrombolytic medications to treat cardiac arrest for FPE. Results  The fatal event of two patients occurred after surgery. Both of them survived with cardiopulmonary resuscitation and administration of thrombolysis and anticoagulation, but one of them had major bleeding during anticoagulation. Six articles were found involving 72473 cases of cardiac arrest due to pulmonary embolism (PE) or unstable massive PE. The thrombolytic agents were recombinant tissue plasminogen activator or streptokinase, but the administration and dose of thrombolytic agents were unclear. Overall, administration of thrombolytics can shorten the time to return of spontaneous circulation and improve the survival rate. There was, however, an increased risk of bleeding events following administration of thrombolytics. Conclusions  Because of the high mortality of cardiac arrest for FPE, the clinician should correctly identify patients with a high likelihood of FPE. Early use of thrombolytics is very important and can potentially improve patient outcomes.

Citation: XuXiaomao, YeXiaohua, QiaoLisong, FangBaomin, SunTieying. Cardiac Arrest Due to Fatal Pulmonary Thromboembolism: Two Cases Report and Literature Review. Chinese Journal of Respiratory and Critical Care Medicine, 2016, 15(2): 166-170. doi: 10.7507/1671-6205.2016039 Copy

  • Previous Article

    Airway Reconstruction supported by Extracorporeal Membrane Oxygenation
  • Next Article

    GSTM5 Down-regulates TNF-α-Mediated Inflammation Levels in Human Bronchial Epithelial Cells by p38MAPK/NF-κB Pathway